We studied 17 short prepubertal children, aged 7.5 to 17.0 years (mean•}SD:
Human growth hormone (HGH) therapy has been attempted in short children to obtain both the normal serum GH responses to provocative stimulation and low sleeprelated serum GH concentrations, and has subsequently increased their growth rates (Wise et al., 1975; Spiliotis et al., 1984) . Furthermore, the plasma somatomedin (SM) levels of such children rose significantly with GH therapy (Kowarski et al., 1978; Rudman et al., 1981; Frazer et al., 1982; Vliet et al., 1983; Gertner et al., 1984) . These results indicate that the GH responses to potent pharmacological stimuli may not always show the true spontaneous GH secretory status. Therefore, we have examined the spontaneous 24-hour GH secretory pattern in short children and compared it with pharmacological GH responses. et al.
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Patients and Methods
Seventeen short children without pubertal development (11 boys and six girls), 7 to 17 years old, were studied (Table 1) . Their mean SD score for height was -3.39+1.03.
The bone ages of their left hands was 1.5-6.0 years younger than their chronological age on the basis of the atlas (Greulich and pyle, 1959) . Their height age lagged behind their chronological age by 2.4-6.7 years. An indwelling catheter was inserted into an antecubital vein in the morning . Blood samples for serum GH were obtained every 20 minutes for 24 hours starting at 8 a . m. The activity and food intake of the subjects were not restricted.
Insulin-arginine tolerance tests (IATT) were performed the next morning. Blood was taken before and at 30, 60, 90, and 120 minutes after a IV bolus injection of 0.1 U/kg body weight of insulin. Following this, arginine was administered IV for 30 minutes at a dose level of 0.5g/kg body weight, and blood samples were obtained at 30, 60, 90, and showed more than five pulses per 24 hours, and their maximum GH levels were greater than 15.6 ng/ml. The 24-h MCGH was also significantly correlated with the maximum GH level during the first three hours of sleep (r=0.76, p<0.01).
Even if the maximum GH levels during the first three hours of sleep were between 7 and 15 ng/ml, some patients (Nos. 2, 3, 9, 11, 12, 13 and 15) did not show normal 24-h MCGH values. And a low 24-h MCGH value was observed in one patient(No. 4) who showed a GH value of less than 7 ng/ml during the first three hours of sleep and more than that value at another time of the day.
GH responses to pharmacological stimuli and plasma SM-C
The GH peak level, the area under the curve in the IATT and the plasma SM-C level are shown in Table 3 . Normal response to either insulin or arginine stimulation Fig. 2 . Relation between 24-hour mean concentration of growth hormone (MCGH ng/ ml) and plasma SM-C (U/ml).
24-h MCGH and SM-C level was observed (r=0.51, p<0.05) (Fig. 2) .
Discussion
The present study showed that many of our patients manifested subnormal physiological GH secretion in spite of normal resposes to pharmacological stimuli. Their 24-h MCGH, number of GH pulses and mean peak amplitude were less than those of normal children (Blatt et al., 1984; Spiliotis et al., 1984) . In short children with normal GH responses to stimulation tests and delayed bone age, low levels of SM have been reported (Hall et al., 1980; Bala et al., 1981; . But the reason for this phenomenon in such short children has not been clarified, although the measurement of GH-dependent plasma SM-C has often been helpful in diagnosing GH deficiency (Furlanetto et al., 1977; D'Ercole et al., 1977) .
In our study, a significant correlation between the 24-h MCGH and plasma SM-C was found, and the mean SM-C level of our patients was significantly lower than that of the control.
These results thus indicate that some short children with normal response to pharmacological stimulation might secrete an insufficient amount of GH physiologically during a 24-hour period. Reports that short children with low SM levels had improved growth with GH therapy (Kowarski et al., 1978; Rudman et al., 1981; Hayek et al., 1981; Frazer et al.,1982; Gertner et al., 1984) support this theory, as does the finding of Zadik et al.(1985) that 45% of short children with normal stimulated GH responses had an integrated concentration of GH within the range of values for the group with GH deficiency.
The measurement of physiological GH levels is a valuable method to use in assessing the lack of GH secretion in short children. Our results indicate that the first three-hour blood sampling during sleep as well as 24-hour blood sampling is suitable for evaluating the physiological secretion of GH. A major GH secretory pulse has been observed within the first few hours of deep sleep (Howse et al., 1977; Cacciari et al., 1978) . There have been a few reports stating that the maximum GH pulse was not necessarily the one associated with the first cycle of the deep sleep stage (Siegel et al., 1984; Howse et al., 1977) . In the patients who did not show a maximum GH level during the first three hours of sleep in this study, however, the maximum GH level obtained at another time of the day was similar.
Furthermore, the patients whose maximum GH level during the first three hours of sleep was lower than 7 ng/ml, but had a maximum GH level of more than 7 ng/ml at another time during the day, showed both a low 24-h MCGH and a low SM-C value. Thus, as the screening test for selecting short children with low physiological GH secretion, 3-h MCGH measurement may be a valuable method.
The maximum GH level during the first three hours of sleep is also useful. However, further study is necessary because some of our patients whose GH level was 10-15 n g/ml during the first three hours of sleep showed a low 24-h MCGH.
Several groups have reported that short children whose nocturnal GH values were somewhat lower than those of controls have accelerated growth after replacement therapy with HGH (Wise et al., 1975; Bierich and Potthoff, 1979; Spiliotis et al., 1984) . Thus, it would be worthwhile to confirm whether these short children can respond to therapy with exogeneous GH. Although some clinical features, such as chronological age, bone age and pretreatment growth rate appear useful in identifying the short children who would respond (Vliet et al., 1983) 
